Teladoc Health, Inc. (NYSE:TDOC) Receives Consensus Recommendation of "Hold" From Brokerages
Teladoc Health, Inc. (NYSE:TDOC) Receives Consensus Recommendation of "Hold" From Brokerages
Shares of Teladoc Health, Inc. (NYSE:TDOC – Get Rating) have received a consensus recommendation of "Hold" from the thirty-five ratings firms that are covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, twenty-one have given a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month price target among analysts that have covered the stock in the last year is $54.59.
据MarketBeat Ratings报道,Teladoc Health,Inc.(纽约证券交易所代码:TDOC-GET Rating)的股票已收到覆盖该公司的35家评级公司的一致建议:持有。两名投资分析师对该股的评级为卖出建议,21名分析师给出了持有建议,四名分析师对该公司发出了买入建议。在过去一年追踪该股的分析师中,平均12个月目标价为54.59美元。
Several analysts have recently issued reports on TDOC shares. Berenberg Bank lowered shares of Teladoc Health from a "buy" rating to a "hold" rating and reduced their target price for the stock from $42.00 to $35.00 in a research note on Tuesday, August 2nd. Needham & Company LLC lowered shares of Teladoc Health from a "buy" rating to a "hold" rating in a research note on Thursday, July 28th. Piper Sandler reduced their price target on shares of Teladoc Health from $42.00 to $40.00 and set an "overweight" rating for the company in a research report on Thursday, July 28th. DA Davidson began coverage on shares of Teladoc Health in a research report on Friday, August 12th. They set a "buy" rating and a $45.00 price target for the company. Finally, Cowen lowered shares of Teladoc Health from an "outperform" rating to a "market perform" rating and reduced their price target for the company from $58.00 to $34.00 in a research report on Tuesday, August 2nd.
几位分析师最近发布了关于TDOC股票的报告。8月2日,贝伦贝格银行在一份研究报告中将Teladoc Health的股票评级从买入下调至持有,并将该股的目标价从42.00美元下调至35.00美元。Needham&Company LLC在7月28日星期四的一份研究报告中将Teladoc Health的股票评级从“买入”下调至“持有”。派珀·桑德勒在7月28日周四的一份研究报告中将Teladoc Health的股票目标价从42.00美元下调至40.00美元,并为该公司设定了“增持”评级。达戴维森在8月12日星期五的一份研究报告中开始报道Teladoc Health的股票。他们为该公司设定了“买入”评级和45.00美元的目标价。最后,考恩在8月2日(星期二)的一份研究报告中将Teladoc Health的股票评级从“跑赢大盘”下调至“市场表现”,并将该公司的目标价从58.00美元下调至34.00美元。
Insider Buying and Selling at Teladoc Health
Teladoc Health的内部交易和销售
In other Teladoc Health news, SVP Daniel Trencher sold 1,000 shares of the stock in a transaction that occurred on Monday, July 18th. The shares were sold at an average price of $41.12, for a total transaction of $41,120.00. Following the transaction, the senior vice president now directly owns 27,408 shares in the company, valued at $1,127,016.96. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, insider Arnnon Geshuri sold 4,098 shares of the firm's stock in a transaction that occurred on Friday, August 26th. The shares were sold at an average price of $34.27, for a total value of $140,438.46. Following the transaction, the insider now owns 76,182 shares in the company, valued at $2,610,757.14. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Daniel Trencher sold 1,000 shares of the firm's stock in a transaction that occurred on Monday, July 18th. The stock was sold at an average price of $41.12, for a total transaction of $41,120.00. Following the completion of the transaction, the senior vice president now owns 27,408 shares in the company, valued at approximately $1,127,016.96. The disclosure for this sale can be found here. Insiders have sold 7,318 shares of company stock worth $255,321 over the last ninety days. Insiders own 1.55% of the company's stock.
在Teladoc Health的其他新闻中,高级副总裁Daniel·特伦彻在7月18日星期一的一笔交易中出售了1,000股该股。这些股票的平均价格为41.12美元,总成交金额为41,120.00美元。交易完成后,高级副总裁现在直接持有该公司27,408股股份,价值1,127,016.96美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的,该文件可以通过此超链接。在其他新闻方面,内部人士Arnnon Geshuri在8月26日星期五的一笔交易中出售了4098股该公司股票。这些股票的平均价格为34.27美元,总价值为140,438.46美元。交易完成后,这位内部人士现在拥有该公司76,182股,价值2,610,757.14美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的,该文件可以通过美国证券交易委员会网站。此外,高级副总裁Daniel·特伦彻在7月18日星期一的一次交易中出售了1,000股该公司的股票。该股以41.12美元的平均价格出售,总成交金额为41120.00美元。交易完成后,高级副总裁现在拥有该公司27,408股股份,价值约1,127,016.96美元。关于这次销售的披露可以找到这里。在过去的90天里,内部人士已经出售了7,318股公司股票,价值255,321美元。内部人士持有该公司1.55%的股份。
Institutional Inflows and Outflows
机构资金流入和流出
Teladoc Health Stock Performance
Teladoc Health股票表现
Shares of TDOC stock opened at $26.23 on Friday. Teladoc Health has a 12 month low of $25.95 and a 12 month high of $156.82. The company has a current ratio of 3.38, a quick ratio of 3.22 and a debt-to-equity ratio of 0.25. The firm has a market capitalization of $4.23 billion, a PE ratio of -0.43 and a beta of 0.86. The firm has a fifty day simple moving average of $33.75 and a two-hundred day simple moving average of $41.67.
上周五,TDOC股票开盘报26.23美元。Teladoc Health的12个月低点为25.95美元,12个月高位为156.82美元。该公司的流动比率为3.38,速动比率为3.22,债务权益比率为0.25。该公司市值为42.3亿美元,市盈率为-0.43,贝塔系数为0.86。该公司的50日简单移动均线为33.75美元,200日简单移动均线为41.67美元。
Teladoc Health (NYSE:TDOC – Get Rating) last posted its earnings results on Wednesday, July 27th. The health services provider reported ($0.44) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.71) by $0.27. Teladoc Health had a negative net margin of 441.94% and a negative return on equity of 2.04%. The firm had revenue of $592.38 million during the quarter, compared to analyst estimates of $586.86 million. Analysts forecast that Teladoc Health will post -1.54 EPS for the current fiscal year.
Teladoc Health(纽约证券交易所代码:TDOC-GET Rating)最近一次公布收益结果是在7月27日星期三。这家医疗服务提供商公布了本季度每股收益(EPS)(0.44美元),比普遍预期的(0.71美元)高出0.27美元。Teladoc Health的净利润率为负441.94%,净资产回报率为负2.04%。该公司本季度营收为5.9238亿美元,而分析师预期为5.8686亿美元。分析师预测,Teladoc Health本财年的每股收益将达到1.54美元。
Teladoc Health Company Profile
Teladoc Health公司简介
(Get Rating)
(获取评级)
Teladoc Health, Inc provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions.
Teladoc Health,Inc.在美国和国际上提供虚拟医疗服务。该公司提供一系列服务和解决方案,涵盖非紧急、间歇性、慢性和复杂的医疗状况,包括糖尿病、高血压、慢性肾脏疾病、癌症、充血性心力衰竭和精神健康状况。
See Also
另请参阅
- Get a free copy of the StockNews.com research report on Teladoc Health (TDOC)
- Humana Proves Vertically Integrated Healthcare Works
- 2 Casino Stocks Worth Taking a Look At
- This Small-Cap Healthcare Name Is Outperforming Its Index
- What Cintas Can Teach Investors About This Bear Market?
- Blackberry Stock Declines As Results Come In Lukewarm Once Again
- 免费获取StockNews.com关于Teladoc Health(TDOC)的研究报告
- Humana证明垂直整合的医疗保健工作
- 值得一看的2只赌场股票
- 这家小盘股医疗保健公司的表现好于其指数
- 关于这个熊市,Cintas能教给投资者什么?
- 黑莓股价下跌,业绩再次不温不火
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.
接受Teladoc健康日报的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Teladoc Health和相关公司的最新新闻和分析师评级的每日简要摘要。